Annual EBITDA
-$496.63M$74.66M+13.07%
Summary
- Current Value
- As of today, BBIO annual EBITDA is -$496.63M, up +13.07% on
- Historical Performance
- BBIO annual EBITDA is down -7.57% over the past 3 years, down -5.35% over the past 5 years
- All-Time High Comparison
- BBIO annual EBITDA is currently -1039.11% below its historical high of -$43.60M set on
- 3-Year Low Comparison
- BBIO annual EBITDA is +16.24% above its 3-year low of -$592.95M reached on
- Sector Comparison
- BBIO annual EBITDA is higher than 1.68% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$496.63M | +13.1% | -7.6% | -5.3% | -1039.1% | |
| Quarterly EBITDA | -$10.57M | +92.2% | +93.2% | +92.9% | +74.7% | |
| TTM EBITDA | -$348.36M | +40.9% | +35.2% | +34.8% | -733.2% | |
| Price | $77.89 | +26.9% | +170.2% | +51.4% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $502.08M | +126.3% | +546.6% | +5986.5% | +100.0% | |
| Annual EPS | -$3.79 | -31.5% | -16.0% | +0.5% | -1124.5% | |
| -$502.06M | +13.0% | -7.2% | -5.8% | -1044.8% | ||
| Annual Net Income | -$732.94M | -34.9% | -51.2% | -45.0% | -1572.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$461.67M | N/A | -7.6% |
| 5Y | -$461.67M | -7.6% | |
| All | -$43.60M | -1039.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$592.95M | +16.2% | |
| 5Y | -$592.95M | +16.2% | |
| All | -$592.95M | +16.2% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$496.63M | +13.1% | |
| -$571.29M | +3.7% | |
| -$592.95M | -28.4% | |
| -$461.67M | +19.1% | |
| -$570.79M | -21.1% |
| Year | Value | Change |
|---|---|---|
| -$471.39M | -77.1% | |
| -$266.24M | -45.0% | |
| -$183.66M | -321.3% | |
| -$43.60M | - |
FAQ
- What is the current annual EBITDA of BBIO?
- As of today, BBIO annual EBITDA is -$496.63M
- What is 1-year change in BBIO annual EBITDA?
- BBIO annual EBITDA is up +13.07% year-over-year
- What is 3-year change in BBIO annual EBITDA?
- BBIO annual EBITDA is down -7.57% over the past 3 years
- How far is BBIO annual EBITDA from its all-time high?
- BBIO annual EBITDA is currently -1039.11% below its historical high of -$43.60M set on December 31, 2017
- How does BBIO annual EBITDA rank versus sector peers?
- BBIO annual EBITDA is higher than 1.68% of companies in Healthcare sector
- When is BBIO next annual earnings release?
- The next annual earnings release for BBIO is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$10.57M$95.46M+90.03%
Summary
- Current Value
- As of today, BBIO quarterly EBITDA is -$10.57M, up +90.03% on
- Historical Performance
- BBIO quarterly EBITDA is up +92.17% year-over-year, up +93.21% over the past 3 years
- All-Time High Comparison
- BBIO quarterly EBITDA is currently -297.98% below its historical high of $5.34M set on
- 3-Year Low Comparison
- BBIO quarterly EBITDA is +95.19% above its 3-year low of -$219.97M reached on
- Sector Comparison
- BBIO quarterly EBITDA is higher than 31.65% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$10.57M | +90.0% | +92.2% | +93.2% | +92.9% | |
| Annual EBITDA | -$496.63M | – | +13.1% | -7.6% | -5.3% | |
| TTM EBITDA | -$348.36M | +26.3% | +40.9% | +35.2% | +34.8% | |
| Price | $77.89 | -5.1% | +26.9% | +170.2% | +51.4% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $353.17M | +44.9% | +192.6% | +8532.9% | +10000.0% | |
| Quarterly EPS | -$0.42 | +45.5% | +55.5% | +60.9% | +60.2% | |
| -$11.64M | +89.1% | +91.5% | +92.6% | +92.2% | ||
| Quarterly Net Income | -$60.50M | +61.2% | +67.3% | +66.3% | +62.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$10.57M | at high | |
| 3Y | $5.34M | -298.0% | |
| 5Y | $5.34M | -298.0% | |
| All | $5.34M | -298.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$134.96M | N/A | +92.2% |
| 3Y | -$219.97M | +95.2% | |
| 5Y | -$219.97M | +95.2% | |
| All | -$219.97M | +95.2% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of BBIO?
- As of today, BBIO quarterly EBITDA is -$10.57M
- What is BBIO quarterly EBITDA most recent change?
- BBIO quarterly EBITDA was up +90.03% on September 30, 2026
- What is 1-year change in BBIO quarterly EBITDA?
- BBIO quarterly EBITDA is up +92.17% year-over-year
- How far is BBIO quarterly EBITDA from its all-time high?
- BBIO quarterly EBITDA is currently -297.98% below its historical high of $5.34M set on March 31, 2024
- How does BBIO quarterly EBITDA rank versus sector peers?
- BBIO quarterly EBITDA is higher than 31.65% of companies in Healthcare sector
- When is BBIO next earnings release?
- The next earnings release for BBIO is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$348.36M$124.39M+26.31%
Summary
- Current Value
- As of today, BBIO TTM EBITDA is -$348.36M, up +26.31% on
- Historical Performance
- BBIO TTM EBITDA is up +40.92% year-over-year, up +35.22% over the past 3 years
- All-Time High Comparison
- BBIO TTM EBITDA is currently -733.16% below its historical high of -$41.81M set on
- 3-Year Low Comparison
- BBIO TTM EBITDA is +48.71% above its 3-year low of -$679.15M reached on
- Sector Comparison
- BBIO TTM EBITDA is higher than 3.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$348.36M | +26.3% | +40.9% | +35.2% | +34.8% | |
| Annual EBITDA | -$496.63M | – | +13.1% | -7.6% | -5.3% | |
| Quarterly EBITDA | -$10.57M | +90.0% | +92.2% | +93.2% | +92.9% | |
| Price | $77.89 | -5.1% | +26.9% | +170.2% | +51.4% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $945.54M | +32.6% | +167.3% | +9929.1% | +1560.2% | |
| TTM EPS | -$3.04 | +14.8% | +27.4% | +22.2% | +22.1% | |
| -$353.11M | +26.1% | +40.6% | +35.1% | +34.4% | ||
| TTM Net Income | -$577.58M | +17.7% | +28.3% | +7.4% | -1.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$348.36M | at high | |
| 3Y | -$348.36M | at high | |
| 5Y | -$348.36M | at high | |
| All | -$41.81M | -733.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$589.60M | N/A | +40.9% |
| 3Y | -$679.15M | +48.7% | |
| 5Y | -$679.15M | +48.7% | |
| All | -$679.15M | +48.7% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of BBIO?
- As of today, BBIO TTM EBITDA is -$348.36M
- What is BBIO TTM EBITDA most recent change?
- BBIO TTM EBITDA was up +26.31% on September 30, 2026
- What is 1-year change in BBIO TTM EBITDA?
- BBIO TTM EBITDA is up +40.92% year-over-year
- How far is BBIO TTM EBITDA from its all-time high?
- BBIO TTM EBITDA is currently -733.16% below its historical high of -$41.81M set on March 31, 2018
- How does BBIO TTM EBITDA rank versus sector peers?
- BBIO TTM EBITDA is higher than 3.21% of companies in Healthcare sector
- When is BBIO next earnings release?
- The next earnings release for BBIO is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- BBIO Official Website bridgebio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1743881/000174388126000009/0001743881-26-000009-index.htm
- BBIO Profile on Yahoo Finance finance.yahoo.com/quote/BBIO
- BBIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bbio